An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix - Wikidata - wikimedia - TriplyDB

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

http://www.wikidata.org/entity/Q35545519

about

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging Imaging tumour hypoxia with positron emission tomography Positron emission tomography to assess hypoxia and perfusion in lung cancer Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.Molecular imaging of hypoxia.Molecular mechanisms of hypoxia in cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET Molecular imaging in cancer treatment.A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.Multimodality imaging of hypoxia in preclinical settings.Positron emission tomography imaging of cancer biology: current status and future prospects Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).Assessing tumor hypoxia by positron emission tomography with Cu-ATSM Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model.64Cu-ATSM Hypoxia Positron Emission Tomography for Detection of Conduit Ischemia in an Experimental Rat Esophagectomy Model.Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.Stroma targeting nuclear imaging and radiopharmaceuticals.First-in-human uPAR PET: Imaging of Cancer Aggressiveness.Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice The role of PET/CT in cervical cancer Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.Copper-64 Radiopharmaceuticals for Oncologic Imaging A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.PET and PET-CT imaging of gynecological malignancies: present role and future promise.Molecular imaging of hypoxia with radiolabelled agents Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.Positron Emission Tomography Imaging of Hypoxia.Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.PET imaging of cardiac hypoxia: opportunities and challenges.Blood flow and associated pathophysiology of uterine cervix cancers: characterisation and relevance for localised hyperthermia.Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Molecular imaging of tumor hypoxia with positron emission tomography.

P2860

Q26784016-B26208ED-EE77-409A-9001-752C50F69EAE Q26851422-497A2268-3D56-485E-9005-E6575393734A Q27026940-A81FA8B5-E5D6-4484-81EE-E8C6786AC547 Q30413615-6C4DE392-D567-477C-8811-47BBE607C1F5 Q30460766-DE1FEC29-1D02-4850-9765-AA96D00D91A3 Q33705108-B7B17B23-1AA0-4CAB-826E-E2C72791DDCB Q33818999-537E9D16-699C-421E-8935-FF211C7591C8 Q33833089-04047100-884B-43C8-B7BD-84F822609EAC Q33870879-36B19B49-0E0D-4BE7-A9FB-6B31209C1DF7 Q34119201-66635895-E694-400A-8A05-C1928C0D4231 Q34235986-C87CA2A3-CF89-4981-9E8A-6B943027C971 Q34496670-B115974C-DD30-4428-8FF1-1CAAD7AC2AB4 Q34512563-FAEB3045-3657-48FA-81E4-2F512EA8034A Q34605956-9D090C55-9E6F-4760-B599-251CE96CECD8 Q34697688-33810F46-8697-4496-BE33-FC21EF949B6B Q35116540-CD13E85B-3495-4643-A676-4C3A83C05FC6 Q35565683-B9E3734E-C606-46A0-9867-9DEB875DB538 Q35580988-6CF107F4-D246-46E1-84D0-EDEA4A1560AA Q35626206-C5B3B66A-7F5E-43E9-83D0-1D5F8947B465 Q35670487-7D37BD36-B035-4ABD-9847-58646A0C386B Q35821298-A99E7A82-F947-4B35-A737-D1C1F91B22BC Q35999606-60EEBCBE-F785-4D23-87CC-3B29906E530E Q36191589-D31E8011-512C-489F-94A3-C9F7AAADEA0F Q36335266-6D69EA5F-8CB8-468E-B2DC-3FE1440193EE Q36637204-18251700-C3C1-4292-9FBC-B744C88F4C3D Q36940477-8BE9745C-8431-4832-93EE-841D361BF105 Q37126530-33DEBF6A-B432-4E83-AD3B-EFBF92F6F2B2 Q37172093-0E36A034-551A-4B5C-8290-08134ABB6BDB Q37236103-5E32AFDD-266E-4075-9039-B0C14E3988D9 Q37357297-EA30C8AE-7232-4AE5-8CEC-48679F3A79C0 Q37378239-1DA3445E-04BF-4064-A71F-3895DA38B65A Q37478003-1096E665-58D4-4FAD-9E83-4013E3E1A6D5 Q37506093-18416414-3389-4C49-9F12-EC9E53BB0896 Q37666742-BD47FE3B-194E-40E0-A779-E0986C5BD591 Q37853427-D0DABD86-D92B-477D-8093-F6AAE4934AC5 Q37869905-2D0ECDB8-A4FC-4D36-81C6-C623975621EE Q37904019-A450A74B-9130-4258-95FE-C9826A8BCC7F Q38030048-03017CB9-1F1D-41B3-BEDF-5D4096A6855B Q38056889-BB978343-F1B1-4DBE-8AD4-695D4A5FC552 Q38199721-4FD19304-7757-421F-B251-9AC9ACD0A970

P2860

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

http://www.wikidata.org/entity/Q35545519

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@ast

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@en

type

label

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@ast

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@en

prefLabel

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@ast

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@en

P1433

Q35545519-A11B77AB-85E9-4255-9EFE-7E8D53844FAE

P1476

Q35545519-2739F65B-24ED-445B-BA52-1D4FD153CEB5

P2093

Q35545519-09B3B208-157F-4E86-81B1-D4A05DF4FF26

Q35545519-2D21DD7F-0741-4381-9B74-AFCC8BBF88FA

Q35545519-5232444F-6F02-423E-A17D-AB9897D6AF61

Q35545519-A5B7B0EA-5BF6-46FC-9743-62DD0E7478C6

Q35545519-E127CBFB-8FEC-4B0F-886F-276BD9B25DF4

Q35545519-FA3F136E-977E-4D4F-9BA4-6FF4EFA79E57

P2860

Q35545519-0B618359-FE14-4EE1-9DFF-549F78D5FA7F

Q35545519-10B4ED99-A58D-442E-BDE7-752208970A82

Q35545519-2A9C3E84-EAF8-48F9-AD15-C31105B1D266

Q35545519-2E657C76-414C-4E36-A246-26A7846BDD2C

Q35545519-30CF95C2-F70F-4F92-A6D8-930E53639D47

Q35545519-3FA828F6-CB45-45F2-9B01-84794554B59B

Q35545519-4413F5C9-02F8-444D-A638-17C4FAA708A6

Q35545519-4656E65A-71AD-4B5C-BAC6-E69792E2A25A

Q35545519-54EE74B0-A135-4B2D-8295-2DB40025AEB7

Q35545519-575B158C-0C05-42E6-90FF-8F09D8D3355C

P304

Q35545519-7EF12770-51FB-443D-AAB8-C04BB683B23B

P31

Q35545519-8ECF1158-340D-4C10-B84E-D156A3DE8A69

P356

Q35545519-86125334-88CE-44C8-89D8-2CDD5F9A34A8

P407

Q35545519-AA522212-D09F-4539-80F6-F68994DF2837

P433

Q35545519-3329CEBD-FE29-4041-AB9F-DCFA2D714D04

P478

Q35545519-37A77A15-10A6-43D3-9114-C4DAA46E2157

P577

Q35545519-C0E26839-BED3-4F77-A404-CEDBB048DA9A

P5875

Q35545519-E2A97DA6-79A8-49A2-A61F-B516D744DAC1

P698

Q35545519-C88EB263-C0E9-4E8E-8FAD-04498B6B1848

P932

Q35545519-659FCFF5-C193-422F-84F1-2C97E161EE59

P356

JNUMED.108.051326

P1433

The Journal of Nuclear Medicine

P1476

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix

@en

P2093

Barry A Siegel

http://www.w3.org/2001/XMLSchema#string

Farrokh Dehdashti

http://www.w3.org/2001/XMLSchema#string

Jason S Lewis

http://www.w3.org/2001/XMLSchema#string

Michael J Welch

http://www.w3.org/2001/XMLSchema#string

Perry W Grigsby

http://www.w3.org/2001/XMLSchema#string

Richard Laforest

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia in cancer: significance and impact on clinical outcome

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.

Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.

Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Copper radionuclides and radiopharmaceuticals in nuclear medicine.

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.

P304

1177-1182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.108.051326

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5303093

http://www.w3.org/2001/XMLSchema#string

P698

18552145

http://www.w3.org/2001/XMLSchema#string

P932

4412029

http://www.w3.org/2001/XMLSchema#string